-
-
in limited clinical trials, metformin has been shown to have anti-cancer activity. The objective of this study was to investigate whether patients taking metformin had better disease-specific survival compared to non-consumers.
-
The authors performed a prospective cohort study, the Contraceptive CHOICE Project, in which women at risk of unintended pregnancy in the St. Louis, Missouri, region received a reversible contraceptive method of their choice for up to 3 years at no cost.
-
-
It has only been a few months since maternal cell free DNA (cfDNA) testing for trisomies 21, 18, and 13 burst onto the scene to shake up (in a good way) current prenatal testing protocols.
-
These two groups took slightly different approaches to assess the relationship between polycystic ovary syndrome (PCOS) and venous thromboembolism (VTE) using insurance claims databases.
-
The authors performed a search of online databases as well as reference lists from published reviews that evaluated methods of pain control in gynecologic procedures using intrauterine instillations.
-
The FDA has approved apixaban the long-awaited third novel oral anticoagulant (NOAC) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF).
-
-
A new study shows that the vast majority of low-lying placentas or marginal previas noted in second trimester patients resolved by term. However, there was a doubling of the rate of postpartum hemorrhage in these patients even if the placentas had migrated away from the cervix.
